Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Assessment of Individual- and Community-level Risks for COVID-19 Mortality in the US and Implications for Vaccine Distribution

View ORCID ProfileJin Jin, View ORCID ProfileNeha Agarwala, View ORCID ProfileProsenjit Kundu, Benjamin Harvey, Yuqi Zhang, Eliza Wallace, Nilanjan Chatterjee
doi: https://doi.org/10.1101/2020.05.27.20115170
Jin Jin
1Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jin Jin
Neha Agarwala
2Department of Mathematics and Statistics, University of Maryland, Baltimore County
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Neha Agarwala
Prosenjit Kundu
1Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Prosenjit Kundu
Benjamin Harvey
1Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yuqi Zhang
3Department of Biomedical Engineering, Johns Hopkins University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eliza Wallace
4PolicyMap Corp, Philadelphia, PA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nilanjan Chatterjee
1Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University
5Department of Oncology, School of Medicine, Johns Hopkins University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: nilanjan@jhu.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Reducing COVID-19 illness and mortality for populations in the future will require equitable and effective risk-based allocations of scarce preventive resources, including early available vaccines. To aid in this effort, we develop a risk calculator for COVID-19 mortality based on various socio-demographic factors and pre-existing conditions for the US adult population by combining information from the UK-based OpenSAFELY study, with mortality rates by age and ethnicity available across US states. We tailor the tool to produce absolute risks for individuals in future time frames by incorporating information on pandemic dynamics at the community level as available from forecasting models. We apply this risk calculation model to available data on prevalence and co-occurrences of the risk-factors from a variety of data sources to project risk for the general adult population across 477 US cities (defined as Census Places) and for the 65 years and older Medicare population across 3,113 US counties, respectively. Validation analyses based on these projected risks and data on tens of thousands of recent deaths show that the model is well calibrated for the US population. Projections show that the model can identify relatively small fractions of the population (e.g. 4.3%) which will lead to a disproportionately large number of deaths (e.g. 49.8%), and thus will be useful for effectively targeting individuals for early vaccinations, but there will be wide variation in risk distribution across US communities. We provide a web-based tool for individualized risk calculations and interactive maps for viewing the city-, county- and state-level risk projections.

Competing Interest Statement

E.W. is an employee of the business corporation PolicyMap Corp. She has not been involved in the design or analysis of the study. She has created the maps with PolicyMap mapping tools with the data provided to her. She has reviewed and commented on the final manuscript.

Funding Statement

The funding for this research came from the Bloomberg Distinguished Professorship endowment of Dr. Nilanjan Chatterjee.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The IRB and ethics committee approvals are exempted because our project does not involve human subject research and it only involves the analysis of publicly available anonymizes data.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Manuscript revised; author list updated; supplementary files updated.

Data Availability

All data used in the manuscript are publically available and can be accessed at https://github.com/nchatterjeelab/COVID19Risk/tree/master/data. All codes for data management and analysis can be accessed at https://github.com/nchatterjeelab/COVID19Risk.

https://github.com/nchatterjeelab/COVID19Risk/tree/master/data

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted August 20, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Assessment of Individual- and Community-level Risks for COVID-19 Mortality in the US and Implications for Vaccine Distribution
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Assessment of Individual- and Community-level Risks for COVID-19 Mortality in the US and Implications for Vaccine Distribution
Jin Jin, Neha Agarwala, Prosenjit Kundu, Benjamin Harvey, Yuqi Zhang, Eliza Wallace, Nilanjan Chatterjee
medRxiv 2020.05.27.20115170; doi: https://doi.org/10.1101/2020.05.27.20115170
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
Assessment of Individual- and Community-level Risks for COVID-19 Mortality in the US and Implications for Vaccine Distribution
Jin Jin, Neha Agarwala, Prosenjit Kundu, Benjamin Harvey, Yuqi Zhang, Eliza Wallace, Nilanjan Chatterjee
medRxiv 2020.05.27.20115170; doi: https://doi.org/10.1101/2020.05.27.20115170

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (215)
  • Allergy and Immunology (495)
  • Anesthesia (106)
  • Cardiovascular Medicine (1093)
  • Dentistry and Oral Medicine (195)
  • Dermatology (141)
  • Emergency Medicine (274)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (499)
  • Epidemiology (9758)
  • Forensic Medicine (5)
  • Gastroenterology (480)
  • Genetic and Genomic Medicine (2304)
  • Geriatric Medicine (222)
  • Health Economics (462)
  • Health Informatics (1554)
  • Health Policy (732)
  • Health Systems and Quality Improvement (602)
  • Hematology (236)
  • HIV/AIDS (501)
  • Infectious Diseases (except HIV/AIDS) (11634)
  • Intensive Care and Critical Care Medicine (616)
  • Medical Education (236)
  • Medical Ethics (67)
  • Nephrology (257)
  • Neurology (2140)
  • Nursing (134)
  • Nutrition (335)
  • Obstetrics and Gynecology (426)
  • Occupational and Environmental Health (517)
  • Oncology (1172)
  • Ophthalmology (363)
  • Orthopedics (128)
  • Otolaryngology (220)
  • Pain Medicine (145)
  • Palliative Medicine (50)
  • Pathology (309)
  • Pediatrics (694)
  • Pharmacology and Therapeutics (298)
  • Primary Care Research (265)
  • Psychiatry and Clinical Psychology (2173)
  • Public and Global Health (4648)
  • Radiology and Imaging (775)
  • Rehabilitation Medicine and Physical Therapy (455)
  • Respiratory Medicine (623)
  • Rheumatology (274)
  • Sexual and Reproductive Health (225)
  • Sports Medicine (210)
  • Surgery (250)
  • Toxicology (43)
  • Transplantation (120)
  • Urology (94)